Amarin Corp Plcuk (AMRN) Change in Cash (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Change in Cash of $12.5 million for Q2 2026, down 55.93% year-over-year from $28.4 million in Q2 2025, and up 447.37% quarter-over-quarter from -$3.6 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Change in Cash (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Change in Cash for 17 consecutive years, with $12.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Cash fell 55.93% year-over-year to $12.5 million; the TTM figure through Jun 2026 stood at -$4.4 million (up 93.53% YoY), while the FY2025 annual figure was $13.5 million, up 117.24% from the prior year.
- Change in Cash climbed to $12.5 million in Q2 2026 per AMRN's latest filing, from -$3.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $41.6 million in Q2 2023 and bottomed at -$71.6 million in Q4 2023.
- Historically, Change in Cash has averaged -$4.4 million across 5 years, with a median of $838500.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Cash sank 8564.69% — and 2025, when it soared 1331.97%.
- Amarin Corp Plc\Uk's Change in Cash stood at -$26.2 million in 2022, then slumped by 172.83% to -$71.6 million in 2023, then soared by 49.51% to -$36.1 million in 2024, then soared by 132.54% to $11.8 million in 2025, then grew by 6.27% to $12.5 million in 2026.
- Business Quant data shows AMRN's Change in Cash at $12.5 million in Q2 2026, -$3.6 million in Q1 2026, and $11.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -4.45 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -727.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.50 Mn |
| Mar 31, 2026 | -3.60 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | -25.07 Mn |
| Jun 30, 2025 | 28.35 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Dec 31, 2024 | -36.13 Mn |
| Sep 30, 2024 | -58.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 14.69 Mn |
| Dec 31, 2023 | -71.56 Mn |
| Sep 30, 2023 | 37.82 Mn |
| Jun 30, 2023 | 41.58 Mn |
| Mar 31, 2023 | -26.25 Mn |
| Dec 31, 2022 | -26.23 Mn |
| Sep 30, 2022 | 12.50 Mn |
| Jun 30, 2022 | 8.85 Mn |
| Mar 31, 2022 | -303,000.00 |
| Dec 31, 2021 | -3.42 Mn |
| Sep 30, 2021 | -104.14 Mn |